SCHEMBL5079577

SCHEMBL5079577

N[C@@H](Cc1c[nH]c2c(Br)cc(Br)cc12)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ BLM P54132 3/20 0.51
▸ PMP22 Q01453 3/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ CYP3A4 P08684 3/20 0.51
▸ TSHR P16473 2/20 0.51
▸ HIF1A Q16665 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ ALOX15 P16050 2/20 0.51
▸ NFKB1 P19838 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ MPO P05164 1/20 0.51
▸ HTR1A P08908 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ HTR2A P28223 1/20 0.51
▸ HTR2C P28335 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26693345 1.00 KMT2A (0.51) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL30678179 1.00 KMT2A (0.51) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL19911037 0.86 TNF (0.58) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL21315702 0.86 TNF (0.58) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL31675799 0.82 PTPRA (0.55) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL1594831 0.81 MAPT (0.62) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL1594834 0.81 MAPT (0.62) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL18029211 0.81 MAPT (0.62) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL7417937 0.78 KMT2A (0.51) KMT2AKDM4ELMNAMAPTBLM
SCHEMBL7417940 0.78 KMT2A (0.51) KMT2AKDM4ELMNAMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS UNIV DANMARKS TEKNISKE (DK) 2025-11-20 — — US disclosed
EP-4526426-A2 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS Danmarks Tekniske Universitet (DK) 2025-03-26 — — EP disclosed
WO-2023222879-A2 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS DANMARKS TEKNISKE UNIVERSITET (DK) 2023-11-23 — — WO disclosed
US-20080096870-A1 Methods and Materials for Treating Mental Illness UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2008-04-24 — — US disclosed
EP-1778211-A1 METHODS AND MATERIALS FOR TREATING MENTAL ILLNESS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2007-05-02 — — EP disclosed
WO-2006020171-A1 METHODS AND MATERIALS FOR TREATING MENTAL ILLNESS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2006-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250354108-A1 METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS INMT, KARS1, MIA3 KMT2A 445/4885KDM4E 2243/4885LMNA 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback